0.30
0.0148 (5.19%)
0.0148 (5.19%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 130,938 |
|
|||||
News | - | ||||||
Day High | 0.2955 | Low High |
|||||
Day Low | 0.27 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bone Biologics Corporation | BBLG | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.28 | 0.27 | 0.2955 | 0.29 | 0.2852 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
272 | 130,938 | $ 0.2855742 | $ 37,393 | - | 0.1777 - 4.07 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:41 | formt | 400 | $ 0.30 | USD |
Bone Biologics Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 4.59M | 15.30M | 8.10M | $ - | $ - | -0.35 | -3.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | - | 27.00% |
Bone Biologics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BBLG Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.2948 | 0.3325 | 0.2674 | 0.2921385 | 183,595 | 0.0052 | 1.76% |
1 Month | 0.2537 | 0.40 | 0.230201 | 0.3035933 | 253,413 | 0.0463 | 18.25% |
3 Months | 0.3127 | 0.44 | 0.1777 | 0.2767681 | 309,986 | -0.0127 | -4.06% |
6 Months | 1.32 | 1.97 | 0.1777 | 0.4961398 | 244,886 | -1.02 | -77.27% |
1 Year | 2.13 | 4.07 | 0.1777 | 1.39 | 209,384 | -1.83 | -85.92% |
3 Years | 4.75 | 7.1219 | 0.1777 | 3.75 | 487,648 | -4.45 | -93.68% |
5 Years | 4.75 | 7.1219 | 0.1777 | 3.75 | 487,648 | -4.45 | -93.68% |
Bone Biologics Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. |